DCE-MRI and Mammography integrated radiomic analysis in triple negative ductal invasive breast cancer patients. Comparison between BRCA and not BRCA mutated patients: preliminary results
Sep 2026· European Journal of Radiology Open· Vol 17, pp. 100810· 0 citations· 40 references
Medicine
TL;DR
A combined radiomic model based on features extracted from DCE-MRI and mammographic images to discriminate the mutational status of BRCA genes in patients with TNBC reinforces the feasibility of radiomics to predict BRCA mutation in patients with TNBC.
Abstract
Purpose We propose a combined radiomic model based on features extracted from DCE-MRI and mammographic images (MG) to discriminate the mutational status of BRCA genes in patients with TNBC. Material and methods This retrospective study included patients histologically diagnosed with TNBC who performed a mammography followed by a DCE-MRI between 2010 and 2021. A manual segmentation was performed on the entire tumor volume on both imaging modalities. Subsequently, a 5-mm ROI was placed within the segmented tumor volume and the contralateral healthy gland. Radiomic features were extracted from these ROIs using Pyradiomics and selected with Maximum Relevance Minimum Redundancy algorithm to fit different classifiers. A final model was developed by integrating the most predictive features extracted from lesion and healthy gland from both modalities into a single multivariate framework. Finally, the added value of an integrated approach was assessed by comparing the performance with single-modality radiomic models. Results The population included 52 patients for a total of 53 lesions (13 BRCA-mutated, 40 non BRCA-carriers). The highest classification performance for BRCA mutational status was achieved by Random Forest that integrated both MRI and mammography features, yielding an Area Under the Curve (AUC) of 0.91. Most predictive features were extracted from healthy gland regions and from MR wash-in/wash-out maps. Multimodal imaging analysis outperformed the best models of single-modality approaches (AUCMG-gland 0.827, AUCMR-gland+lesion 0.80). Conclusions This study reinforces the feasibility of radiomics to predict BRCA mutation in patients with TNBC, highlighting the possibility of integrating different imaging modalities to enhance model accuracy.
MRI provides superior accuracy in assessing tumor size and disease extent and remains the preferred staging modality, however, CEM offers excellent performance in evaluating multifocality, multicentricity, and laterality, making it a valuable alternative when MRI is unavailable or contraindicated.
Micheal Saber Nan Georgy, R. H. Abdallah, Ahmed Gamal Eldeen Othman et al.· Clinica Terapeutica· 0 citations
Background Differentiating the immunohistochemical and histopathological features of ductal carcinoma in situ (DCIS) lesions is critical to potentially enable future tailored treatment options and de-escalation strategies. Purpose To investigate the potential of magnetic resonance imaging (MRI) radiomics for the non-in...
A. A. Tan, Amir Bakhshandehpour, Ümran Esen et al.· Acta Radiologica· 0 citations
The clinical–radiomics nomogram shows promising potential for differentiating lymphoma from CUP in poorly differentiated cervical lymph node malignancies and warrants further validation in larger, multi-center cohorts before clinical implementation.
Positron emission mammography (PEM) is a valuable tool for assessing the extent of disease in newly diagnosed breast cancer patients, particularly among women pursuing conservative surgical management. The aim of this study was to evaluate the added diagnostic value of preoperative Positron Emission Mammography (PEM) i...
E. Kamal, Mahmoud Mekhaimar, R. Hamid et al.· The Egyptian Journal of Radi...· 0 citations
Background: Breast cancer molecular subtypes differ biologically and may exhibit distinct imaging phenotypes. This study examined whether mammographic morphologic features corresponding to the low-energy structural component of contrast-enhanced mammography (CEM) were associated with molecular subtype. Methods: A retro...
Wael Ahmed Maher Mostafa ElHik· Natural Resources for Human...· 0 citations
RATIONALE AND OBJECTIVES
To develop and validate a habitat radiomics model based on pretreatment breast magnetic resonance imaging (MRI) in predicting residual axillary lymph node metastasis (RALNM) after neoadjuvant therapy (NAT) in patients with clinically node-positive (cN+) breast cancer.
MATERIALS AND METHODS
Th...
Junjie Zhang, Yi Dai, Ruxin Xu et al.· Academic Radiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.